|
Authorized Generic Deals Could Be Gone With New Ruling, Lawyer Says
Drug companies’ patent settlements may no longer contain clauses preventing authorized generic (AG) launches after Monday’s landmark court decision on pay-for-delay deals, a pharma lawyer says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives